GWM
JAZZ icon

Geneos Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Geneos Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Buy
45
+12
+36% +$2.63K ﹤0.01% 1997
2026
Q1 		$6.24K Hold
33
– – ﹤0.01% 2115
2025
Q4 		$5.61K Hold
33
– – ﹤0.01% 2111
2025
Q3 		$4.35K Sell
33
-320
-91% -$38.4K ﹤0.01% 2170
2025
Q2 		$37.5K Sell
353
-22
-6% -$2.39K ﹤0.01% 1724
2025
Q1 		$46.6K Buy
375
+137
+58% +$17.9K ﹤0.01% 1513
2024
Q4 		$29.3K Sell
238
-8
-3% -$943 ﹤0.01% 1549
2024
Q3 		$27.4K Buy
246
+213
+645% +$23.3K ﹤0.01% 1433
2024
Q2 		$3.52K Buy
33
+2
+6% +$220 ﹤0.01% 1787
2024
Q1 		$3.73K Hold
31
– – ﹤0.01% 1774
2023
Q4 		$3.81K Hold
31
– – ﹤0.01% 1791
2023
Q3 		$4.01K Hold
31
– – ﹤0.01% 1805
2023
Q2 		$3.84K Hold
31
– – ﹤0.01% 1806
2023
Q1 		$4.54K Hold
31
– – ﹤0.01% 1756
2022
Q4 		$4.94K Hold
31
– – ﹤0.01% 1706
2022
Q3 		$4K Sell
31
-15
-33% -$2.28K ﹤0.01% 1741
2022
Q2 		$7K Hold
46
– – ﹤0.01% 2086
2022
Q1 		$7K Sell
46
-18
-28% -$2.61K ﹤0.01% 2226
2021
Q4 		$8K Sell
64
-172
-73% -$22.6K ﹤0.01% 2265
2021
Q3 		$30K Sell
236
-12
-5% -$1.81K ﹤0.01% 1724
2021
Q2 		$45K Buy
248
+46
+23% +$7.97K ﹤0.01% 1532
2021
Q1 		$33K Hold
202
– – ﹤0.01% 1830
2020
Q4 		$33K Buy
+202
New +$30.1K ﹤0.01% 1662
2016
Q4 		– Sell
-103
Closed -$12K – 2072
2016
Q3 		$12K Buy
103
+3
+3% +$404 ﹤0.01% 1307
2016
Q2 		$14K Hold
100
– – ﹤0.01% 1228
2016
Q1 		$13K Buy
+100
New +$12.4K ﹤0.01% 1221

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geneos Wealth Management's JAZZ Position: Q2 2026 in Review

Geneos Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 36% in Q2 2026, buying an estimated $2.63K and bringing the position to 45 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1997.

Geneos Wealth Management first reported a position in JAZZ in Q1 2016 and has held it in 26 quarters since. The position peaked at $46.6K in Q1 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Geneos Wealth Management held 45 shares of Jazz Pharmaceuticals worth $10.8K as of Q2 2026.
  • Geneos Wealth Management bought 12 Jazz Pharmaceuticals shares in Q2 2026, an estimated $2.63K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1997 holding.
  • Geneos Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2016 and has held it in 26 quarters since.
  • Geneos Wealth Management's Jazz Pharmaceuticals position peaked at $46.6K in Q1 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.